Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients

Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients

Objective: the development and verification of a scale for identifying patients at high risk of osteoarthritis (OA).Material and methods. The results of the analysis of a sample of patients aged 35–90 years from the database of the Institute of Trace Elements (n=3440), which included information on...

Full description

Bibliographic Details
Main Authors: I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova
Format: Article
Language:Russian
Published: IRBIS LLC 2021-01-01
Series:Фармакоэкономика
Subjects:
osteoarthritis
joint pathology
osteoarthritis risk assessment scale
osteoarthritis prevention
symptomatic slow-acting drugs for osteoarthritis
sysadoa
topological recognition theory
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/768

Internet

https://www.pharmacoeconomics.ru/jour/article/view/768

Similar Items